Navigation Links
NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace
Date:6/18/2014

A collaboration between the National Science Foundation (NSF) and the National Institutes of Health will give NIH-funded researchers training to help them evaluate their scientific discoveries for commercial potential, with the aim of accelerating biomedical innovations into applied health technologies.

I-Corps at NIH is a pilot of the NSF Innovation Corps (I-Corps) program specially tailored for biomedical research. Academic researchers and entrepreneurs with Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) Phase I awards awards that establish feasibility of proof of concept for commercializable technology from participating NIH institutes will be eligible to apply to I-Corps at NIH. NIH will begin outreach to the small business research community with a June 25 program briefing at the 2014 BIO International Convention in San Diego, and a webinar on July 2.

The I-Corps Teams curriculum is a nine-week boot camp in which experienced business-savvy instructors work closely with teams of researchers to help them explore potential markets for their federally funded innovations. I-Corps instructors take a scientific method-based approach to customer discovery that resonates with scientists and engineers. While I-Corps instructors typically have a wide range of expertise, I-Corps at NIH will be taught by instructors who have biomedical business experience.

Providing tools for prospective entrepreneurs

The NIH institutes that will participate in the pilot program are the National Cancer Institute, the National Heart, Lung and Blood Institute, the National Institute of Neurological Disorders and Stroke, and the National Center for Advancing Translational Sciences.

Michael Weingarten, director of the NCI SBIR Development Center, said he and his colleagues initially reached out to NSF because they witnessed the difference I-Corps made for the graduates. To date, more than 300 three-person teams have completed the NSF I-Corps training, including those supported by the Department of Energy's Advanced Research Projects Agency.

"I-Corps will help teach NIH-funded start-ups how to build scalable business models around new technologies they're developing for the detection and treatment of disease. The program sheds new light on how companies can deal with important business risks such as protecting intellectual property, and developing regulatory and reimbursement strategies," Weingarten said.

I-Corps will supplement SBIR/STTR awardees' scientific skills through real time interactions with over 100 potential customers to validate their technology's market potential. The 24 selected teams will receive supplemental funding from NIH to support entrepreneurial training, mentorship and collaboration opportunities.

"This new collaboration with NIH is further evidence of the flexibility and efficacy of the I-Corps model," said Pramod Khargonekar, NSF assistant director for engineering. "Translating basic biomedical research to the marketplace has its own particular set of challenges, which we recognize. By focusing and adapting the I-Corps curriculum to the life sciences, we expect biomedical researchers will be better-equipped to enter the business arena."

NIH awards more than $700 million in SBIR/STTR research and development awards each year. "This pilot will leverage NIH's robust SBIR/STTR program and further NIH's mission to advance our understanding of human illness and treatment of disease and disability," said NIH SBIR/STTR program coordinator Matthew Portnoy. "We look forward to this collaborative endeavor with NSF."

A sustainable innovation ecosystem

The I-Corps network continues to undergo strategic expansion.

In addition to the pilot, existing NIH-funded programs can apply to become new NSF I-Corps sites to broaden the I-Corps network. These programs include the NIH Centers for Accelerated Innovation and Research Evaluation and Commercialization Hubs, which focus on academic researchers with technologies that have not yet led to the formation of a startup or have been licensed by an existing company.

All people and organizations involved in I-Corps become part of the NSF-established National Innovation Network, a nationwide web created to leverage the community that has developed among the grantees to increase the program's impact.

NCI will lead outreach to the small business community in coming weeks, beginning with a briefing on the program at the 2014 BIO International Convention, the world's largest gathering of the biotechnology industry, on June 25 from 2-3 p.m. PDT in San Diego and a webinar on July 2. Steve Blank, a serial entrepreneur and academic who developed the original course which I-Corps is based on, will participate in both events.


'/>"/>

Contact: NIH National Cancer Institute Office of Communications
ncipressofficers@mail.nih.gov
301-496-6641
NIH/Office of the Director
Source:Eurekalert

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. BGI and Aspera collaborate on high-speed data exchange to advance genome research
3. Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
4. USDA scientists collaborate with global researchers to advance the mapping of the barley genome
5. ALS TDI and Gladstone Institutes collaborate to discover potential ALS treatments
6. Springer will collaborate with the Italian Society for Ultrasound in Medicine and Biology
7. Springer to collaborate with Scion on open access journal
8. Feinstein Institute collaborates with GSK, UPenn, MIT to research bodys electrical impulses
9. OU researchers collaborate on $20 million NSF EPSCoR grant
10. TabletKiosk and SMI Collaborate to Produce the Sahara EyeSlate
11. NJIT professor collaborated on new federal report on Deepwater Horizon oil spill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2018)... ... November 29, 2018 , ... Tosoh Bioscience LLC announced it ... full ownership. The transaction was approved by the Board of Directors of both ... are extremely pleased to team up with Tosoh Bioscience to offer customers the ...
(Date:11/27/2018)... ... 26, 2018 , ... PulseEd™ uses researched technology, published in the Journal ... blood flow to the penis. Regular and unimpeded blood flow to the blood vessels ... erectile function. The recorded results of SWT (sound wave therapy), indicated that almost 80% ...
(Date:11/27/2018)... POWAY, Calif. (PRWEB) , ... November 27, 2018 , ... Veni Vici, or Anthony, is ... tear in his right knee. At the time, he was fourteen years old and ... would ever be well enough to be a trail horse. Devasted, Lisa sought the ...
Breaking Biology News(10 mins):
(Date:11/20/2018)... ... ... Each year Forbes receives thousands of nominations for candidates wishing to be selected ... 30 years of age. The Forbes 30 Under 30 list showcases the top 30 ... and Science. , In 2017, Visikol CEO Dr. Michael Johnson was named to ...
(Date:11/13/2018)... POWAY, Calif. (PRWEB) , ... November 13, 2018 , ... ... to patients on the island of Kauai. Dr. Leadbeater, of Kahala ... cell services since 2009. Recently, he began traveling to the island of Kauai ...
(Date:11/13/2018)... (PRWEB) , ... November 13, 2018 , ... ... analysis of the spine technology market last week that asserts it is still ... patient population. , Humad’s analysis describes market consolidation, pricing pressure and ...
(Date:11/11/2018)... , ... November 09, 2018 , ... Triple W, an ... CES® 2019 Innovation Awards Honoree for DFree ®, the first health tech ... when it’s time to go to the bathroom. The announcement was made during CES ...
Breaking Biology Technology: